Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Comp Neurol ; 498(4): 508-24, 2006 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-16874802

RESUMEN

Gamma-hydroxybutyrate (GHB) is a substance derived from the metabolism of GABA and is heterogeneously distributed in various regions of the brain. This compound possesses a neuromodulatory role on several types of synapses, particularly those using GABA as a neurotransmitter. At physiological concentrations, this effect of GHB is mediated via specific receptors that induce neuronal hyperpolarization and bind radioactive GHB with a specific distribution, ontogenesis, kinetics, and pharmacology. A membrane protein that possesses six to seven transmembrane domains and which binds and is activated by micromolar amounts of GHB was recently cloned from rat brain hippocampus. In order to study the regional and cellular distribution of this receptor in rat brain, we selected several specific peptides belonging to the extracellular domains of the receptor to be used as specific immunogens to raise polyclonal antibodies in the rabbit. Among the antisera obtained, one of them gave particularly good results in terms of specificity and reactivity at high dilution. Immunohistochemical analyses, both at the confocal and electron microscopic level, showed receptor protein distribution closely resembling the distribution of GHB high-affinity binding sites, except for cerebellum, where GHB receptor(s) of lower affinity exist(s). In all regions studied the GHB receptor-like protein labeling appears to be distributed specifically in neurons and not in glial cells. At the cellular level the antibody specifically labels dendrites, and no immunoreactivity was detected in presynaptic endings or in axons. Accordingly, electron microscopy reveals strong labeling of postsynaptic densities and of neuronal cytosol.


Asunto(s)
Encéfalo/metabolismo , Receptores de Superficie Celular/metabolismo , Ácido gamma-Aminobutírico/metabolismo , Animales , Encéfalo/fisiología , Encéfalo/ultraestructura , Células CHO , Cricetinae , ADN Complementario/análisis , Electrofisiología , Hidroxibutiratos , Inmunohistoquímica/métodos , Masculino , Técnicas de Cultivo de Órganos , Ratas , Ratas Wistar , Receptores de Superficie Celular/genética , Receptores de Superficie Celular/fisiología , Distribución Tisular , Transfección
2.
Epilepsia ; 46(1): 141-5, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15660780

RESUMEN

PURPOSE: The aim of this study was to investigate whether the nucleus parafascicularis (Pf) of the thalamus could be a relay of the control of epileptic seizures by the superior colliculus (SC). The Pf is one of the main ascending projections of the SC, the disinhibition of which has been shown to suppress seizures in different animal models and has been proposed as the main relay of the nigral control of epilepsy. METHODS: Rats with genetic absence seizures (generalized absence epilepsy rat from Strasbourg or GAERS) were used in this study. The effect of bilateral microinjection of picrotoxin, a gamma-aminobutyric acid (GABA) antagonist, in the SC on the glutamate and GABA extracellular concentration within the Pf was first investigated by using microdialysis. In a second experiment, the effect of direct activation of Pf neurons on the occurrence of absence seizures was examined with microinjection of low doses of kainate, a glutamate agonist. RESULTS: Bilateral injection of picrotoxin (33 pmol/side) in the SC suppressed spike-and-wave discharges for 20 min. This treatment resulted in an increase of glutamate but not GABA levels in the Pf during the same time course. Bilateral injection of kainate (35 pmol/side) into the Pf significantly suppressed spike-and-wave discharges for 20 min, whereas such injections were without effects when at least one site was located outside the Pf. CONCLUSIONS: These data suggest that glutamatergic projections to the Pf could be involved in the control of seizures by the SC. Disinhibition of these neurons could lead to seizure suppression and may be involved in the nigral control of epilepsy.


Asunto(s)
Epilepsia Tipo Ausencia/prevención & control , Epilepsia Tipo Ausencia/fisiopatología , Glutamatos/fisiología , Núcleos Talámicos Intralaminares/efectos de los fármacos , Núcleos Talámicos Intralaminares/fisiopatología , Colículos Superiores/efectos de los fármacos , Colículos Superiores/fisiopatología , Animales , Modelos Animales de Enfermedad , Electroencefalografía/estadística & datos numéricos , Agonistas de Aminoácidos Excitadores/farmacología , Líquido Extracelular/química , Líquido Extracelular/efectos de los fármacos , Antagonistas del GABA/farmacología , Glutamatos/análisis , Glutamatos/efectos de los fármacos , Núcleos Talámicos Intralaminares/química , Ácido Kaínico/administración & dosificación , Ácido Kaínico/farmacología , Masculino , Microdiálisis , Microinyecciones , Vías Nerviosas/efectos de los fármacos , Vías Nerviosas/fisiopatología , Picrotoxina/administración & dosificación , Picrotoxina/farmacología , Ratas , Ratas Endogámicas , Sustancia Negra/fisiopatología , Ácido gamma-Aminobutírico/análisis , Ácido gamma-Aminobutírico/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA